Clinical Trial

The pros and cons of split-dose granulocyte colony-stimulating factor alone rather than a single high dose for hematopoietic progenitor cell mobilization in small children (< 15 kg) with solid tumors

Vol. 91 No. 7 (2006): July, 2006